IMPACTS OF DIFFERENT CONCENTRATIONS OF AQUEOUS GREEN TEA EXTRACT ADMINISTERED DURING METHOTREXATE TREATMENT ON SOME SELECTED BLOOD INDICES IN RATS
Objective: This study was designed to investigate the impacts of administering of different concentrations of Aqueous Green Tea Extract (AGTE) (0.625, 1.25 or 2.5%) during Methotrexate (MTX) treatment, and continued for 5 days, on blood indices in rats.
Methods:Six groups of white Albino rats were utilized: Â Group I- (Control, received water); Group II- [single i. p. injection (20 mg/kg) of MTX], Group III- [1.25% concentration of AGTE alone for 5 days], and Groups IV, V and VI- [rats were administered, respectively AGTE (0.625, 1.25 or 2.5%), during MTX treatment, and continued for 5 days].
Results:The results showed that MTX alone induced significant decreases in Hb, HCT, MCHC, MCH, RBCs, and total WBCs; Â while, it increased platelets count. Administration of different concentrations of AGTE during MTX produced significant decrease in total WBCs and platelets; Â while significant increase in Hb, HCT, MCHC, MCH; Â meanwhile, significant increase, or decrease, respectively in MCV (depending on the concentration of AGTE); and a significant increase in RBCs only was seen at 2.5% AGTE plus MTX), compared to MTX-treated animals.
Conclusion: Marked alterations in blood indices were obtained from this study when AGTE was administered during MTX treatment. So this study recommends taking into account such administration when MTX is therapeutically utilized.
2. Schalinske KL, Steele RD. Methotrexate alters carbon flow through the hepatic folate-dependent one-carbon pool in rats. J Carcinogenesis 1996;17:1695â€“700.
3. Cutolo M, Seriolo B, Pizzorni C, et al. Methotrexate in psoriatic arthritis. J Clin Exp Rheumatol 2002;20:S76â€“S80.
4. Fraser AG. Methotrexate: first-line or second-line immune modulator?. Eur J Gastroenterol Hepatol 2003;15:225â€“31.
5. Schroder O, Stein J. Low-dose methotrexate in inflammatory bowel disease: current status and future directions. Am J Gastroenterol 2003;98:530â€“7.
6. Uz E, Oktem F, Yilmaz HR, Uzar E, Ozguner F. The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. J Mol Cell Biochem 2005;277:165â€“70.
7. Hall PM, Jenner MA, Ahern MJ. Hepatotoxicity in a rat model caused by orally administered methotrexate. J Hepatology 1991;14:906â€“10.
8. Ã‡etiner M, Åžener G, A Ã–zer Åžehirli, EkÅŸioÄŸlu-Demiralp E, Ercan F, ÅžirvancÄ± S, et al. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. J Toxicol Appl Pharmacol 2005;209:39 â€“ 50.
9. Minaur NJ, Kounali D, Vedi S, Compston JE, Beresford JN, Bhalla AK. Methotrexate in the treatment of rheumatoid arthritis. In vivo effects on bone mineral density. J Rheum 2002;41:714-49.
10. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. J Food Chem Toxicol 2008;46:1271â€“8.
11. Tedeschi E, Suzuki H, Menegazzi M. Anti-inflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. J Ann NY Acad Sci 2002;973:435â€“7.
12. Khan N, Mukhtar H. Tea polypohenols for health promotion. J Life Sci 2007;81:519â€“33.
13. Hamilton-Miller, JMT. Anti-cariogenic properties of tea (Camellia Sinensis). J Med Microbiol 2001;50:299â€“302.
14. Mohamadina AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. J Pharmacol Res 2005;51:51-7.
15. Åžener G, EkÅŸioÄŸlu-Demiralpb E, Ã‡etinerb M, Ercanc F, YeÄŸen BÃ‡. Î²-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects. Eur J Pharmacol 2006;542:170â€“8.
16. 16 Kim E, Barrett KE, Barman SM, Boitano S, Brooks H, Lange, et al. Ganong's Review of Medical Physiology, 24th Edition. (Science) McGraw-Hill Medical; 2011. p. 546-50.
17. Banji D, Pinnapureddy J, Banji OJF, Kumar AR, Reddy KN. Evaluation of the concomitant use of methotrexate and curcumin on Freund's complete adjuvant-induced arthritis and hematological indices in rats. Indian J Pharmacol 2011;43(5):546-50.
18. Robbins TJ, Bowen D, Bui QQ, Tran M. Modulation of high-dose methotrexate toxicity by a non-toxic level of 5-fluorouracil. J Toxicology 1986;41:61â€“73.
19. Van Ede AE, Laan RF, Blom HJ, De Abreu RA, Van de Putte LB. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. J Semin Arthritis Rheum 1998;27:277-92.
20. Smith C, Lieberman M, Marks DB, Marks AD. Marks' essential medical biochemistry. Hagerstwon, MD: Lippincott Williams & Wilkins; 2007. ISBN 0-7817-9340-8.
21. Ajit KS, Saxena AK, Divya S, Gajendra S. Structural interaction between drug-DNA and protein-?A novel approach for Bioinformatics in medicine. J Biomed Res 2009;20:28-34.
22. Rossi S. Australian Medicines Handbook ed 2013.
23. Kremer JM. Toward a better understanding of methotrexate. J Arthritis Rheum 2004;50:1370â€“82.
24. Cimen MY. Free radical metabolism in human erythrocytes. J Clin Chim Acta 2008;390:1-11.
25. Cabezas-Herrera J, Durrant M, Thorneley RNF Navarro-PerÂ´an E, GarcÂ´Ä±a-CÂ´anovas FC, RodrÂ´Ä±guez-LÂ´opez JN. The antifolate activity of tea catechins. J Cancer Res 2005;65:2059-64.
26. Elbling L, Weiss RM, Teufelhofer O, Uhl M, Knasmueller S, Shulte-Hermann R, et al. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin exert oxidant but lack antioxidant activities. FASEB J 2005;19:807â€“9.
27. Giuseppe Galati a, Alison Lin b, Amira M, Sultan b, Peter J, Oâ€™Brien. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and Catechins. J Free Rad Bio Med 2006;40:570 â€“80.
28. Gad SB, Zaghloul DM. Beneficial Effects of Green Tea Extract on Liver and Kidney Functions, Ultrastructure, Lipid Profile and Hematological Parameters in Aged Male Rats. J Global Veterinaria 2013;11 (2):191-205.
29. Cabezas-Herrera J Navarro-MartÂ´Ä±nez MD, Navarro-PerÂ´an E, Ruiz-GÂ´omez J, GarcÂ´Ä±a-CÂ´anovas F, RodrÂ´Ä±guez-LÂ´opez JN. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. J Antimicrob Agents Chemother 2005;49:2914-20.
30. Cabezas-Herrera J, Hiner ANP, Sadunishvili T Navarro-PerÂ´an E, GarcÂ´Ä±a-CÂ´anovas F, RodrÂ´Ä±guez-LÂ´opez JN. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies. J Biochemistry 2005;44:7512-25.